Literature DB >> 312270

Cyclosporin A: in vivo and in vitro suppression of rat T-lymphocyte function.

J J Burckhardt, B Guggenheim.   

Abstract

The immunosuppressive effect of cyclosporin A (CS-A) was investigated in RIC-Sprague-Dawley rats. In vivo, CS-A totally abolished the formation of antibodies to the hapten dinitrophenyl (DNP) in rats immunized with DNP-keyhole limpet haemocyanin. In vitro, the effect of CS-A was investigated in spleen cell cultures stimulated by concanavalin A, phytohaemagglutinin or lipopolysaccharide. The suppression due to CS-A was more pronounced in cultures set up with cells from rats fed the drug than in spleen cell cultures from control animals supplemented with serum containing CS-A. Purified by filtration through Degalan-rat Ig-anti IgG columns, T lymphocytes from CS-A treated rats were no longer suppressed by CS-A serum in contrast to purified T cells obtained from control rats. Thus, CS-A seems to interfere with the mitogenic triggering of a subpopulation of T lymphocytes resulting in a functional clonal deletion.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 312270      PMCID: PMC1457658     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  9 in total

1.  Lymphocyte proliferation in vitro induced by soluble protein antigens. II. Cellular requirements.

Authors:  B Hertel-Wulff; B Rubin
Journal:  Eur J Immunol       Date:  1976-06       Impact factor: 5.532

2.  Biological effects of cyclosporin A: a new antilymphocytic agent.

Authors:  J F Borel; C Feurer; H U Gubler; H Stähelin
Journal:  Agents Actions       Date:  1976-07

3.  [Cyclosporin A, a Peptide Metabolite from Trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity].

Authors:  A Rüegger; M Kuhn; H Lichti; H R Loosli; R Huguenin; C Quiquerez; A von Wartburg
Journal:  Helv Chim Acta       Date:  1976       Impact factor: 2.164

4.  Immune responses in vitro. I. Culture conditions for antibody synthesis.

Authors:  R E Click; L Benck; B J Alter
Journal:  Cell Immunol       Date:  1972-02       Impact factor: 4.868

Review 5.  The regulatory influence of activated T cells on B cell responses to antigen.

Authors:  D H Katz; B Benacerraf
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

6.  Are Actinomyces viscosus antigens B cell mitogens?

Authors:  J J Burckhardt; B Guggenheim; A Hefti
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

7.  Rat memory T lymphocytes: in vitro proliferation induced by antigens of Actinomyces viscosus.

Authors:  J J Burckhardt
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

8.  The effect of cyclosporin A on dental caries in rats monoassociated with Actinomyces viscosus NY 1.

Authors:  B Guggenheim; A Hefti; J J Burckhardt
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

9.  Effects of the new anti-lymphocytic peptide cyclosporin A in animals.

Authors:  J F Borel; C Feurer; C Magnée; H Stähelin
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

  9 in total
  15 in total

1.  Cyclosporin A -- a new outlook for immunosuppresion in clinical transplantation.

Authors:  P J Tutschka
Journal:  Blut       Date:  1979-08

2.  Hepatic and renal function in rats receiving immunotherapeutic doses of cyclosporin A.

Authors:  P H Whiting; A W Thomson; I D Cameron; J G Simpson
Journal:  Br J Exp Pathol       Date:  1980-12

3.  Suppression of delayed-type hypersensitivity reactions and lymphokine production by cyclosporin A in the mouse.

Authors:  A W Thomson; D K Moon; D S Nelson
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

4.  Selective induction of immunological tolerance in antiviral T killer cells of inbred mice after treatment with cyclosporin A.

Authors:  D Armerding
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

5.  Activity of cyclosporin A in experimental influenza virus infection in mice.

Authors:  R M Cook
Journal:  Agents Actions       Date:  1983-02

6.  Modification of delayed-type hypersensitivity reactions to ovalbumin in cyclosporin A-treated guinea-pigs.

Authors:  A W Thomson; D K Moon; Y Inoue; C L Geczy; D S Nelson
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

7.  Fatty acid metabolism and cell proliferation: IV. Effect of prostanoid biosynthesis from endogenous fatty acid release with cyclosporin-A.

Authors:  J A Lindsey; N Morisaki; J M Stitts; R A Zager; D G Cornwell
Journal:  Lipids       Date:  1983-08       Impact factor: 1.880

8.  Cyclosporin A: a new advance in transplantation.

Authors:  B D Kahan
Journal:  Tex Heart Inst J       Date:  1982-09

9.  Stage-selective inhibition of rodent malaria by cyclosporine.

Authors:  J R Murphy; S Baqar; R H Baker; E Roberts; S P Nickell; G A Cole
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

10.  Suppression of experimental allergic neuritis by Cyclosporin-A.

Authors:  R H King; R I Craggs; M L Gross; C Tompkins; P K Thomas
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.